Systemic sclerosis (scleroderma): open trials in Spain

• NCT06925542

  A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  Trial Treatment · Phase 1 · CRISPR Therapeutics

  Hospital Universitario Reina Sofia, Córdoba · Clinica Universidad de Navarra - Pamplona, Pamplona · Hospital Universitario Virgen del Rocio, Seville · Hospital Clinico Universitario de Valencia, Valencia

  Registry updated 2026-10-26

• NCT05878717

  A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  Trial Treatment · Phase 2/3 · GlaxoSmithKline

  Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Universitario Clínico San Cecilio, Granada · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario de Navarra, Pamplona · Parc Tauli Hospital Universitari, Sabadell · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Universitario Rio Hortega, Valladolid · Complexo Hospitalario Universitario De Vigo, Vigo

  Registry updated 2026-09-08

• NCT06195072

  Platform Clinical Study for Conquering Scleroderma

  Trial Treatment · Phase 2 · Scleroderma Research Foundation, Inc.

  Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Reina Sofia, Córdoba · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Dr. Peset Aleixandre, Valencia

  Registry updated 2026-08-18

• NCT06991114

  AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.

  Artiva Investigational Site Sevila, Seville

  Registry updated 2026-07-31

• NCT07115745

  A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Ramón y Cajal, Madrid

  Registry updated 2026-07-14

• NCT07348263

  EFESO: Study on Juvenile Onset Eosinophilic Fasciitis

  Research · Meyer Children's Hospital IRCCS

  Hospital Sant Joan de Déu, Barcelona

  Registry updated 2026-03-11

All Systemic sclerosis (scleroderma) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error